Hoffman testified that most of the girls wanted to get off the drugs, but were afraid to try.
“There are all kinds of punishments that you have to be fearful of," she said, "if you are to refuse medication that is prescribed to you by a psychiatrist that only meets with you for an hour a month.”
Sen. Mike McGuire (D-San Rafael) chairs the Senate Oversight Committee for Human Services.
“All too often, wonder drugs have become the first response in this state," he said. “We all know we must do better.”
Over the last 10 years, McGuire said, Medi-Cal, the state's health insurance program for people who are low income, has spent $226 million on psychotropic medication. More than 70 percent of that money was spent on foster children.
McGuire pressed state agency representatives at the hearing on whether they agreed that prescription rates were far too high.
“There’s very deep concern about the volume,” responded Will Lightbourne, head of the Department of Social Services, the agency which oversees foster care.
Lightbourne said an overhaul of California’s foster care system already underway reflects that concern. The state seeks to expand alternative therapies for kids, restrict the use of psychotropic drugs -- especially prescribing drugs to control kids’ behavior -- and reduce the number of children sent to group homes and shorten their stays. “All that says, yes, we want to bring those numbers down,” Lightbourne said.
But he cautioned that it would be take years to achieve the reforms.
State lawmakers at the hearing planned to move forward with reforms of their own.
Sen. Jim Beall (D-San Jose), the chair of the Senate Committee on Mental Health, said he would introduce two bills to protect foster children.
One bill would require public health nurses to oversee foster kids’ medication; another would establish treatment protocols and oversight in group homes.